Global Glutathione Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, And Growth Forecast To 2027

Glutathione Market

Glutathione, also known as GSH, is a naturally occurring antioxidant that is produced by the liver. It is composed of three amino acids: cysteine, glycine, and glutamate. Glutathione plays a crucial role in protecting cells from oxidative stress, which can damage DNA and contribute to the development of diseases such as cancer, Parkinson's, and Alzheimer's.

The growing demand for natural food preservatives is expected to drive the growth of the Glutathione Market in the food and beverage industry. Additionally, it helps to support the immune system, detoxify the body, and maintain healthy skin. Due to these benefits, the glutathione market has been growing steadily in recent years.

Market Overview

The global Glutathione Market was valued at USD 191.8 million in 2020 and is expected to grow at a CAGR of 8.2% from 2021 to 2028.

The increasing demand for glutathione in the food and beverage industry, as well as the pharmaceutical and cosmetic industries, is expected to drive the growth of the market.

Food and Beverage Industry

Glutathione is widely used as a food additive in the food and beverage industry. It acts as a natural preservative, helping to extend the shelf life of food products. Additionally, it can enhance the flavor and color of foods, making it a popular ingredient in the production of meat, dairy, and bakery products.

Throughout the projected period, the worldwide Nutricosmetics Market is anticipated to increase as a result of rising consumer awareness, busy lifestyles, and the desire for personal grooming in Asia Pacific.

Pharmaceutical Industry

The pharmaceutical industry is another major user of glutathione. It is used in the production of drugs for the treatment of various diseases such as cancer, HIV/AIDS, and liver diseases. Glutathione is also used in the treatment of respiratory diseases such as chronic obstructive pulmonary disease (COPD) and asthma. The increasing prevalence of these diseases is expected to drive the growth of the Glutathione Market in the pharmaceutical industry.